Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2024 Aug;133(2):213-215.
doi: 10.1016/j.anai.2024.05.015. Epub 2024 Jun 3.

The use of dupilumab in treatment-refractory eosinophilic fasciitis

Affiliations
Case Reports

The use of dupilumab in treatment-refractory eosinophilic fasciitis

Chen Wang et al. Ann Allergy Asthma Immunol. 2024 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none.

References

    1. Mazori DR, Femia AN, Vleugels RA. Eosinophilic Fasciitis: an Updated Review on Diagnosis and Treatment. Curr Rheumatol Rep 2017;19(12):74. doi: 10.1007/s11926-017-0700-6 - DOI - PubMed
    1. Mufti A, Kashetsky N, Abduelmula A, Lytvyn Y, Sachdeva M, Yeung J. Biologic treatment outcomes in refractory eosinophilic fasciitis: A systematic review of published reports. J Am Acad Dermatol 2022;86(4):951–953. doi: 10.1016/j.jaad.2021.03.089 - DOI - PubMed
    1. Nguyen JK, Austin E, Huang A, Mamalis A, Jagdeo J. The IL-4/IL-13 axis in skin fibrosis and scarring: mechanistic concepts and therapeutic targets. Arch Dermatol Res 2020;312(2):81–92. doi: 10.1007/s00403-019-01972-3 - DOI - PMC - PubMed
    1. Boothby IC, Kinet MJ, Boda DP, Kwan EY, Clancy S, Cohen JN, et al. Early-life inflammation primes a T helper 2 cell-fibroblast niche in skin. Nature. 2021;599(7886):667–672. doi: 10.1038/s41586-021-04044-7 - DOI - PMC - PubMed
    1. Lebeaux D, Francès C, Barete S, Wechsler B, Dubourg O, Renoux J, et al. Eosinophilic fasciitis (Shulman disease): new insights into the therapeutic management from a series of 34 patients. Rheumatology (Oxford). 2012;51(3):557–561. doi: 10.1093/rheumatology/ker366 - DOI - PubMed

Substances

Supplementary concepts